Control Of Spasticity In A Multiple Sclerosis Model Is Mediated By CB1, Not CB2, Cannabinoid Receptors

Multiple Sclerosis (MS)

Key Findings

CB(1) receptor is the main cannabinoid target for an antispastic effect.

Information and Links


Link: Control Of Spasticity In A Multiple Sclerosis Model Is Mediated By CB1, Not CB2, Cannabinoid Receptors

Year: 2007

DOI: 10.1038/sj.bjp.0707003


Ratings

(How Ratings Work)

Multiple Sclerosis (MS) — 2


Possible to probable range of efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.

Drugs Used

Endocannabinoid agonists